Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 70

Sort by

Sort Order Select

Journal Articles

Community health worker contacts for high utilizer vs. other sickle cell patients in an adult sickle cell disease medical home

Andrea Burton, Shirley Johnson, Daniel Sop, Yue Zhang, Wally Smith

Blood (2025) 146 (Supplement 1): 4368.

https://doi.org/10.1182/blood-2025-4368

Published: 2025

Journal Articles

Contact modality and contact intensity over time among community health workers in adult sickle cell disease

Andrea Burton, Daniel Sop, Shirley Johnson, Yue Zhang, Wally Smith

Blood (2025) 146 (Supplement 1): 4367.

https://doi.org/10.1182/blood-2025-4367

Published: 2025

Journal Articles

Role efficiency in psychosocial care of sickle cell disease: A national survey of social workers

Shirley Johnson, Daniel Sop, Spencer Moorman, Yue Zhang, Wally Smith

Blood (2025) 146 (Supplement 1): 6417.

https://doi.org/10.1182/blood-2025-6417

Published: 2025

Journal Articles

Face validity of progressive rank criteria to identify high-utilizer sickle cell patients in an adult sickle cell disease medical home

Wally Smith, Daniel Sop, Yue Zhang, Andrea Burton, Shirley Johnson

Blood (2025) 146 (Supplement 1): 2594.

https://doi.org/10.1182/blood-2025-2594

Published: 2025

Journal Articles

Humanized KLKB1 provides a mouse model for evaluating the knockdown efficacy of RNAi therapies

Fengxing Gu, Jianling Huo, Yue Zhang, Hui Xu, Ziqi Chen, Xiaofei Zhou, Qiurong Wang

Blood (2025) 146 (Supplement 1): 7843.

https://doi.org/10.1182/blood-2025-7843

Published: 2025

Journal Articles

Selinexor combined with pegaspargase and dexamethasone, followed by radiotherapy, for newly diagnosed stage I–II natural killer/T-cell lymphoma: A multicenter, single-arm, Phase I/II study

Siyu Qian, Yue Zhang, Mingzhi Zhang, Xudong Zhang

Blood (2025) 146 (Supplement 1): 5429.

https://doi.org/10.1182/blood-2025-5429

Published: 2025

Journal Articles

Comparative effectiveness of emergency department versus pain infusion clinic management for acute pain in adults with sickle cell disease: Implications for cost and timeliness of care

Daniel Sop, Yue Zhang, Shirley Johnson, Andrea Burton, April Goode, Wally Smith

Blood (2025) 146 (Supplement 1): 122.

https://doi.org/10.1182/blood-2025-122

Published: 2025

Journal Articles

Evolving annual community health worker time allocation to maximize sickle cell disease medical home efficiency

Shirley Johnson, Daniel Sop, Yue Zhang, Andrea Burton, Wally Smith

Blood (2025) 146 (Supplement 1): 6148.

https://doi.org/10.1182/blood-2025-6148

Published: 2025

Journal Articles

Distance to specialized care predicts emergency department, pain infusion clinic, and inpatient utilization patterns in adults with sickle cell disease

Daniel Sop, Yue Zhang, Shirley Johnson, Andrea Burton, April Goode, Wally Smith

Blood (2025) 146 (Supplement 1): 7966.

https://doi.org/10.1182/blood-2025-7966

Published: 2025

Journal Articles

IMV101, a novel CD19-targeted In Vivo CAR T therapy exhibits potent efficacy and tolerable safety profiles in preclinical models

Shuangshuang Zhang, Yantao Li, Xiaojiang Fan, Qiaoyong Yi, Yue Zhang, Linke Bian, Jiufei Zhu, Minmin Sun, Zhenggang Jiang, Ruidong Hao

Blood (2025) 146 (Supplement 1): 5875.

https://doi.org/10.1182/blood-2025-5875

Published: 2025

Journal Articles

Behavioral health and biophysical complexity as predictors of healthcare utilization in adults with sickle cell disease

Daniel Sop, Yue Zhang, Shirley Johnson, Andrea Burton, April Goode, Wally Smith

Blood (2025) 146 (Supplement 1): 4364.

https://doi.org/10.1182/blood-2025-4364

Published: 2025

Journal Articles

Clinical and molecular features of immunodeficiency in patients with telomere biology disorders

Luiz Fernando Bazzo Catto, Nidhi Aggarwal, Ruba Shalhoub, Xiaoyang Ma, Ivana Darden, Tania Machado, Yue Zhang, Neelam R. Redekar, Natthakan Thongon, Simona Colla, Geraldine Aubert, Cynthia E. Dunbar, Colin O. Wu, Neal S. Young, Bhavisha A. Patel, Fernanda Gutierrez-Rodrigues, Emma M. Groarke

Blood (2025) 146 (10): 1187–1193.

https://doi.org/10.1182/blood.2024026735

Published: 2025

Includes: Supplemental data

Journal Articles

Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPN

Blood (2024) 144 (22): 2336–2348.

https://doi.org/10.1182/blood.2024024373

Published: 2024

Includes: Supplemental data

Journal Articles

Pola-Based Framework Regimen Treating DLBCL in Real World at Renji Hospital of China

Jun Du, Jue Wang, Zi-Yu Feng, Lan Xu, Fei Xiao, Jia Liu, Dan Xiao, Wan-Bin Fu, Min-Yue Zhang, Li-Jing Shen, Lu Zhong, Hua Zhong, Jian Hou, Hong-Hui Huang, Ting Wang

Blood (2024) 144 (Supplement 1): 7729.

https://doi.org/10.1182/blood-2024-206799

Published: 2024

Journal Articles

Quality of Life Evaluation for Patients on Ropeginterferon Alpha-2b Versus Other Best Available Therapies

Brynn Parsegov, Halee Namanny, Maren Campbell, Yue Zhang, Feiyun Yan, Michael Christiansen, Amanda Smith, Tsewang Tashi, Josef T. Prchal

Blood (2024) 144 (Supplement 1): 1791.

https://doi.org/10.1182/blood-2024-204440

Published: 2024

Journal Articles

A Layered Cloaking Strategy to Generate Allogeneic iPSC-Derived CD8 T-Cells That Evade NK Clearance

Siddarth Chandrasekaran, Vignesh Janardhanam, Ian Cardle, Justin Yoo, Yue Zhang-Wong, Julia Bershadsky, Elisa Martinez, April Marple, Laxsha Thaya, Charlie Liu, Dhanya Vijayan, Leanne Jamieson, Lifu Sheng, Elizabeth Csaszar, Emily Titus, Chris Bond

Blood (2024) 144 (Supplement 1): 2045.

https://doi.org/10.1182/blood-2024-210003

Published: 2024

Journal Articles

TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice

Blood (2023) 141 (26): 3184–3198.

https://doi.org/10.1182/blood.2022018619

Published: 2023

Includes: Supplemental data

Journal Articles

Discovery of INCA033989, a Monoclonal Antibody That Selectively Antagonizes Mutant Calreticulin Oncogenic Function in Myeloproliferative Neoplasms (MPNs)

Edimara Reis, Rebecca Buonpane, Hamza Celik, Caroline Marty, Angela Lei, Fatoumata Jobe, Mark Rupar, Yue Zhang, Darlise DiMatteo, Rahel Awdew, William Vainchenker, Jing Zhou, Ian Hitchcock, Isabelle Plo, Horacio Nastri, Patrick Mayes

Blood (2022) 140 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2022-159435

Published: 2022

Journal Articles

CAR-T Cell Therapy of Solid Tumors Invokes an Expanded Set of Myeloid Cells in an Orthotopic Tumor Model for Rhabdomyosarcoma

Peter Sullivan, Yue Zhang, Virginia Hoglund, Sophie Jamet, Isela J Garcia, Rimas J Orentas

Blood (2022) 140 (Supplement 1): 10277–10278.

https://doi.org/10.1182/blood-2022-164779

Published: 2022

Journal Articles

CD22 CAR-T Induces Both CD19 and CD22 Surface Down-Modulation: Defining a Mechanism of Generalized Immune Evasion and the Effects of Epigenetic Modifiers

Lingyan Wang, PhDDVM, Yue Zhang, MS, Eden Anderson, BS, Rajesh Kumar, PhD, Adam J. Lamble, MD, Rimas J Orentas, PhD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-134930

Published: 2020

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Community health worker contacts for high utilizer vs. other sickle cell patients in an adult sickle cell disease medical home

Contact modality and contact intensity over time among community health workers in adult sickle cell disease

Role efficiency in psychosocial care of sickle cell disease: A national survey of social workers

Face validity of progressive rank criteria to identify high-utilizer sickle cell patients in an adult sickle cell disease medical home

Humanized KLKB1 provides a mouse model for evaluating the knockdown efficacy of RNAi therapies

Selinexor combined with pegaspargase and dexamethasone, followed by radiotherapy, for newly diagnosed stage I–II natural killer/T-cell lymphoma: A multicenter, single-arm, Phase I/II study

Comparative effectiveness of emergency department versus pain infusion clinic management for acute pain in adults with sickle cell disease: Implications for cost and timeliness of care

Evolving annual community health worker time allocation to maximize sickle cell disease medical home efficiency

Distance to specialized care predicts emergency department, pain infusion clinic, and inpatient utilization patterns in adults with sickle cell disease

IMV101, a novel CD19-targeted In Vivo CAR T therapy exhibits potent efficacy and tolerable safety profiles in preclinical models

Behavioral health and biophysical complexity as predictors of healthcare utilization in adults with sickle cell disease

Clinical and molecular features of immunodeficiency in patients with telomere biology disorders

Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPN

Pola-Based Framework Regimen Treating DLBCL in Real World at Renji Hospital of China

Quality of Life Evaluation for Patients on Ropeginterferon Alpha-2b Versus Other Best Available Therapies

A Layered Cloaking Strategy to Generate Allogeneic iPSC-Derived CD8 T-Cells That Evade NK Clearance

TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice

Discovery of INCA033989, a Monoclonal Antibody That Selectively Antagonizes Mutant Calreticulin Oncogenic Function in Myeloproliferative Neoplasms (MPNs)

CAR-T Cell Therapy of Solid Tumors Invokes an Expanded Set of Myeloid Cells in an Orthotopic Tumor Model for Rhabdomyosarcoma

CD22 CAR-T Induces Both CD19 and CD22 Surface Down-Modulation: Defining a Mechanism of Generalized Immune Evasion and the Effects of Epigenetic Modifiers

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only